News Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
3,719 ^JPY	-0.51%		-4.86%	-13.73%

Apr. 11	Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	MT
Jan. 12	Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	Apr. 11	MT
Hisamitsu Pharmaceutical : Earning Document	Apr. 11	PU
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”	Mar. 13	PU
Final dividend	Feb. 27	FA
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	Jan. 12	MT
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024	Jan. 11	CI
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024	Jan. 11	CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	Dec. 26	CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.	Dec. 24	CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	Dec. 05	CI
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	Dec. 04	PU
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.	23-10-31	PU
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales	23-10-08	MT
Hisamitsu Pharmaceutical : Earning Document	23-10-06	PU
Hisamitsu Pharmaceutical : Earning Document	23-10-06	PU
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023	23-10-06	CI
Hisamitsu Pharmaceutical : Notification regarding Skin Care Cosmetics with Microneedle Technology	23-09-20	PU
Hisamitsu Pharmaceutical : Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)	23-09-19	PU
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	23-09-04	CI
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	23-09-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Summary

Filters